converting the inactive Gα·βγ complex into an active GTP-Gα, which then dissociates from Gβγ to allow for activation of AC (Gilman, 1987) . More recently, a broadened concept of "preformed complexes" that include GPCR dimers, G protein heterotrimers, effectors, and possibly other regulators, is gaining acceptance (Gales et al., 2005; Rebois et al., 2006) . The evidence in support of this idea comes from biochemical and FRET/BRET studies on the effector proteins AC, inward rectifying K + channels (GIRK) (Rebois et al., 2006) , and PLCβ (Yuan et al., 2007) . New models suggest a rearrangement and only a partial separation of GTP-Gα from Gβγ, such that the effector binding sites at the interface between Gα and Gβγ become exposed (Bünemann et al., 2003; Frank et al., 2005) . Despite growing acceptance of this model, many key issues remain unresolved. We suggest that it is the effectors themselves that may help to hold G protein subunits in close proximity. We show herein that the N-terminus of AC5 (5NT) anchors "inactive" heterotrimeric G-proteins (GDP-Gαs·βγ). The heterotrimeric G protein binding site was mapped to amino acid region 60-129 of 5NT. Deletion of this region in full length AC resulted in a significant reduction of FRET between AC5 and Gβγ. Despite reduced FRET, mutant AC5 was stimulated by exogenously added GTPγS-Gαs and Gβγ suggestive of a separate activation site for Gβγ on AC5. We also show that AC5 NT interacts with its catalytic domains (5C1/5C2) to enhance the Gαs or forskolin stimulated activity of C1/C2. We propose that the Nterminus of AC5 is as a key regulatory domain that brings the inactive heterotrimeric G-proteins and catalytic core in close proximity for efficient GPCR activation.
MATERIALS AND METHODS
Materials. Antibodies used were rabbit-anti-Gαs (Calbiochem ), rabbit-anti-Gβ  (Santa Cruz ), mouse-anti-GST (Santa Cruz), rabbit-anti-H6 (Bethyl), rabbit-anti-AC5 (Santa Cruz and Core therapeutics), and anti-flag agarose (Sigma).
Plasmids Construction and Generation of Recombinant Viruses. Human AC5 N-terminus (5NT) was fused with GST (GST-5NT) in pGEX-CS vector (Gao et al., 2007) . 6NT was generated by PCR, fusing human AC6 aa 1-143 to GST in pGEX-4T vector. Truncations of 5NT fused with GST (Δ60, Δ 144, were generated by PCR.
AC5Δ66-137 was created using PCR, deleting aa residues 66-137 within full length hAC5-pcDNA3. N-terminally tagged YFP-AC5 was created in multiple steps. YFP tagged pcDNA3
was created by PCR, generating Kpn1 and BamH1 sites at the 5' and 3' ends of YFP, respectively. Human AC5 was subcloned in two steps into the BamHI and XbaI sites of YFPpcDNA3. YFP-AC5Δ66-137 was created by subcloning the SacII-NotI fragment from AC5Δ 66-137 pcDNA3 into YFP-AC5 pcDNA3. Sequences were confirmed by nucleotide sequencing and restriction digests. N-terminal flag-tagged human AC5 and cerulean tagged Gβ1 were generous gifts from Drs. Michael Kapiloff and Moritz Bünemann, respectively (Bünemann et al., 2003) .
Recombinant baculoviruses for full length AC5 and AC5Δ66-137 were created and expressed as previously described (Chen-Goodspeed et al., 2005) .
Tissue Culture and Transfection. Human Embryonic Kidney cells (HEK293) and COS7 cells
were maintained in Dulbecco's modified Eagle's media supplemented with 10% (v/v) fetal bovine serum and 50 µg/ml penicillin and streptomycin. For transient expression of proteins, cells were plated 24 hours prior to transfection. Transfections were performed using Lipofectamine-2000 (Invitrogen) or Jet PEI (Genesse Scientific) as per manufacturer's protocol.
After 48 hrs of transfection, cells were used for the desired experiment.
Protein Purification. Proteins 5C1(670)H 6 , H 6 5C2, Gαs-H 6 , and myristoylated Gαi-H 6 were expressed in Escherichia coli and purified as previously described (Dessauer et al., 1998; Sunahara et al., 1997; Whisnant et al., 1996) . GST-tagged proteins were purified using glutathione agarose resin (Salim et al., 2003) . Non-tagged Gβ 1 γ 2 was co-expressed with in Sf9 cells and purified on Ni-NTA followed by ion-exchange as previously described (Kozasa and Gilman, 1995) .
GST Pull-Down Assays. GST or GST-5NT (full length or truncations) were incubated with Gprotein subunits in 50 µl binding buffer (20 mM Hepes, pH 8.0, 1mM EDTA, 5 mM MgCl 2 , 1 mM DTT, 50 mM NaCl, 0.2% C 12 E 9 and 2 µM GDP). For assays utilizing the cytoplasmic domains (5C1 or 5C2), the binding buffer included 0.05% C 12 E 9 and no GDP. The proteins were incubated for 30 min at 4°C followed by addition of 100 µl of 20% glutathione-agarose beads.
After rotating for 2 hrs, the resin was washed three times with binding buffer containing 150 mM NaCl and 0.05% C 12 E 9 . For incubations containing 5C1 and 5C2 the NaCl was increased to 250 mM. Bound proteins were eluted with 15 mM glutathione, boiled with Laemmli buffer and analyzed by SDS-PAGE and western blotting.
Immunoprecipitation of AC5. Human flag-tagged AC5 was transfected in HEK293 cells (10 cm dish/IP). After 48 hrs HEK293 cells were rinsed with PBS, resuspended in lysis buffer (20 mM Hepes, pH 8.0, 1mM EDTA, 1 mM MgCl 2 , 1 mM DTT, 150 mM NaCl, 0.5% C 12 E 10 , 1 µM GDP, and protease inhibitors), and homogenized using a 23-gauge syringe. Cellular debris was removed by centrifugation, and 30 µl of anti-flag agarose was added. Samples were rotated at 4°C for 2 h, and then washed three times with lysis buffer that contained only 0.05% C 12 E 10 .
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Gel Filtration Chromatography. Proteins (10 µM, 100 μl sample volume) were applied on tandem superdex 75/200 columns (GE Healthcare) and resolved in gel filtration buffer (20 mM Hepes pH 8.0, 1mM EDTA, 5 mM MgCl 2 , 1 mM DTT, 100 mM NaCl, 0.05% C 12 E 9 and 10 μM GDP) at 0.3 ml/min, 4°C. Fractions (0.4 ml) were collected and samples were analyzed by SDS-PAGE and immunoblotting.
Preparation of Membranes from HEK293 and Sf9 cells. HEK293 cells were transfected with 10 µg of total DNA (per 10 cm plate) that included 2.5 μg of plasmid encoding AC5 or AC5Δ66-137. Membranes were prepared after 48 hrs as described (Piggott et al., 2008) . Membranes from Sf9 cells expressing AC5 or AC5Δ66-137 were prepared after 48 hrs of infection with the respective baculovirus as described in .
Assay of Adenylyl Cyclase Activity. AC activity was measured in membranes as previously described (Dessauer, 2002) . In assays containing purified 5C1 and 5C2 catalytic domain proteins, limiting concentrations of the C1 domain protein were assayed with 1 μM of 5C2 to promote interaction between the C1 and C2 proteins as previously described (Whisnant et al., 1996) . GST or GST-5NT was preincubated with 5C1/5C2 prior to addition of activators.
Fluorescence Resonance Energy Transfer (FRET).
Cell preparation: COS7 cells were plated on poly-L-lysine (0.01 mg/ml) coated coverslips in 6-well dishes at ~10-15% confluency. The next day cells were transfected with 2 μg of total DNA, which included 0.4 μg of YFP-AC5 or YFP-AC5Δ66-137, 0.9 μg Cerulean-Gβ1, and 0.7 µg of Gγ2. Prior to imaging, media was exchanged with tyrodes buffer (10 mM HEPES, pH 7.4, 145 mM NaCl, 4 mM KCl, 1 mM bound to the NT of human AC5 (5NT) (Gao et al., 2007) . Gβγ has no effect on AC activity alone, but increases the activity of AC5 and AC6 approximately 1.5 -2 fold in the presence of Gαs or forskolin. To further examine the nature of this interaction, we sought to compete Gβγ binding to 5NT by addition of an excess of GDP-bound Gα, which should mask the Gβγ effector surface. Numerous crystallographic and mapping studies have identified an overlapping surface on Gβγ that is used for both binding to alpha subunits and various effectors (Wall et al., 1995) .
However not only did GDP-Gαs fail to compete with binding of Gβγ to GST-5NT, it actually enhanced binding over two fold (Fig. 1A ). In addition, the alpha subunit also bound to 5NT in the absence of Gβγ (Fig. 1A ,B). Gαs binding to 5NT was enhanced by Gβγ when present in the GDP-bound, aluminum fluoride-bound, and to GTPγS-bound state ( Fig 1A, B and S1). At the concentrations of G proteins used in these binding assays (1 μM), a complex of Gαβγ would be expected since the affinity of GDP-Gαs for Gβγ is 27 nM under the conditions used in our binding assays (Sarvazyan et al., 2002) . Therefore, separate sites on Gαs and Gβγ are likely utilized to bind 5NT compared to the Gα-βγ interaction surface or effectors binding sites on Gαs and Gβγ.
Apparent Affinity Measurements for G protein Binding to AC 5NT. To further characterize
interactions with 5NT, we determined the apparent affinities for binding Gβγ or Gα. Increasing amounts of GDP-bound Gα or Gβγ were added to GST-5NT (125-150 nM) and GST-pull down assays were performed (Fig. 1B ). Binding to GST alone was tested at the highest level for each protein (3 µM). Binding data was quantitated from three independent experiments to determine apparent affinities ( Fig 1B) . Gβγ (190 ± 7 nM) and GDP-Gαs (270 ± 21 nM) binding to 5NT
This article has not been copyedited and formatted. The final version may differ from this version. was saturable and displayed fairly high affinity binding. GTPγS-and GDP-bound Gαs displayed similar binding to 5NT and was comparable to the affinity of GTPγS-bound Gαs for the activation site on the C2 domain of AC5 (400 nM) (Sunahara et al., 1997) . GDP-bound myristoylated Gαi 1 also bound to 5NT but with a much reduced apparent affinity (~1.5 µM)
compared to GDP-bound Gαs.
Isolation of AC5/Gαs·βγ Complex. To show that it is indeed the heterotrimer that is bound to 5NT, we used gel filtration chromatography to evaluate the size and composition of potential complexes between GDP-Gαs, Gβγ, and 5NT ( Fig 1C) . An approximately 90 kDa complex of Gαs·βγ can be isolated by gel filtration which shifts in the presence of 5NT to a complex of 140-145 kDa. This is consistent with a 1:1:1 complex consisting of 5NT/Gαs·βγ. Smaller complexes of 5NT with either Gαs or Gβγ are also evident. Note that GST-tagged 5NT runs mainly as a monomer of 50 kDa but is also found at lower levels as a dimeric species, likely due to the tendency of GST to dimerize. Thus our results suggest that inactive heterotrimeric Gs can bind to AC5, challenging the dogma that heterotrimeric G proteins only interact with effectors in their "activated" GTP-bound state.
Gαs·βγ can also be found in complex with full-length AC5. Endogenous Gαs and Gβγ are readily detectable in immunoprecipitations of flag-tagged AC5 from HEK293 cells ( Fig 1D) .
This is consistent with a model in which heterotrimeric G proteins do not release from the effector and are poised to allow for regulation of AC by both subunits. (Fig. 2B) . These results were confirmed by gel-filtration chromatography where 5NT-60-129 clearly formed a complex with Gαs·βγ heterotrimer but Δ144 did not ( Fig. 2C and S2 ).
G-Protein Subunits
We previously identified aa 77-151 in AC 6NT as necessary for Gβγ regulation (Gao et al., 2007) . In general, the N-terminal domains of different AC isoforms have little similarity;
however there are small stretches of homology between aa 60-129 of 5NT and 77-151 of 6NT.
We now show that both GDP-Gαs and Gβγ directly interact with 6NT as well (Fig. S3 ).
5NT Interacts with the Catalytic Core to Enhance Gs or Forskolin Stimulated Activity.
The question remained as to how the NT may be regulating functional properties of AC. Previous reports have suggested that AC could act as a GAP or possibly GEF for Gαs (Scholich et al., 1999) , however, purified 5NT displays neither of these activities for Gαs or Gαi (Fig. S4) .
Rather, the NT pulls down a complex of 5C1/5C2/Gαs in the presence or absence of forskolin and binds directly to the C1 domain of AC5 (Fig. 3A , B and S5), and to a lesser degree the C2 domain ( Fig 3C) . This interaction is isoform specific, as there is no interaction between the Nterminus of AC2 and the C1 domain of AC5 (Fig 3A) . We have further mapped the binding site of the C1 and C2 domains on 5NT to aa 60-144, similar to that of the G protein subunits, however C1 does not compete with Gαs or Gβγ for 5NT binding (Fig. 3D, E ). Computer modeling of 5NT suggests that this region is highly helical and thus different faces of this helix may be required for interactions with the C1 domain and heterotrimeric G proteins.
Most intracellular regulators of AC activity bind to the C1 and C2 domains of AC to exert their stimulatory or inhibitory affects. Thus it is possible that the NT can also affect the enzymatic state of AC5. 5NT increased the activity of the isolated C1 and C2 domains of AC5
This article has not been copyedited and formatted. The final version may differ from this version. 4A ). AC5Δ66-137 can be activated by Gαs and/or forskolin when assayed in membranes from HEK293, COS7, and Sf9 cells (Fig. 4B, 4D , and 5A). However, AC5Δ66-137 displayed a small but highly reproducible 38% right shift of the Gαs dose-response curve (P<0.05, n=6). AC5Δ66-137 was also conditionally stimulated by exogenously added Gβγ, suggesting that AC5 activation by Gβγ does not require its binding to the N-terminus (Fig. 4D ).
Previous studies have suggested that deletion of residues 1-86 of AC6 increases Gαi inhibition . We examined the inhibition of AC5Δ66-137 by GTPγS-Gαi in the presence and absence of Gβγ. Consistent with previous studies, deletion of 66-137 increased Gαi efficacy and the IC 50 compared to wild type AC5. This is likely due to the loss of 5NT interactions with the C1 domain, which binds GTPγS-Gαi ( Fig. 4E ; (Dessauer et al., 1998; Kao et al., 2004) . Upon addition of Gβγ, the percent inhibition of wild-type AC5 by Gαi increased and was nearly identical to AC5Δ66-137 in the presence of Gβγ. Thus, Gβγ binding appears to reverse the constraints of the N-terminus on Gαi inhibition, although the overall activity is still increased by Gβγ. (Fig. 5A ). In addition, both YFP-AC5 and YFP-AC5Δ66-137 were found to be largely localized to the PM when expressed in HEK293 or COS7 cells at low levels (Fig. 5B ). Higher levels of expression generally produced a particulate cytoplasmic fluorescence that was excluded from the nucleus. Therefore, we have carefully titrated AC expression levels that give rise to a largely PM expression pattern for all fluorescence and activity assays. Although previous reports have suggested that AC5 may be present on the nuclear envelope in cardiac myocytes (Belcheva et al., 1995; Boivin et al., 2006; Yamamoto et al., 1998) , we detected no such localization upon expression in COS7 cells.
To analyze G protein interactions with AC5 in living cells, we used a FRET-based approach employing YFP-tagged AC5 and N-terminal Cerulean tagged Gβ1 (Cer-Gβ1). Cer-Gβ1 has previously been characterized for its plasma membrane localization and interactions with Gγ2 and Gαi (Bünemann et al., 2003) . There is a strong inverse distance relationship between FRET and the distance separation between chromophores, such that FRET between the donor molecule CFP and acceptor molecule YFP only occurs if the two proteins are in close proximity (<100 Å). Significant FRET was observed at the plasma membrane between YFP-AC5 and Cer-Gβ1γ2 compared to myristoylated tagged CFP and YFP-AC5 (negative control;
Fig 5B, and C). In addition, no significant FRET was observed between Cer-Gβ1γ2 and the transmembrane protein YFP-Na,K-ATPase (data not shown). Numerous mathematical methods are used to quantify FRET. We compared the two most commonly used methods F C /D (Vanderklish et al., 2000) and N FRET (Xia and Liu, 2001) . Using either method, a significant decrease in FRET was observed for YFP-AC5Δ66-137 and Cer-Gβ1γ2 as compared to YFPThis article has not been copyedited and formatted. The final version may differ from this version. 
DISCUSSION
In this report, we show by various biochemical techniques that 1) preformed complexes occur between AC5 and heterotrimeric G-proteins (GDP-Gαs·βγ), 2) these complexes are mediated by the N-terminus of AC5, and 3) the N-terminus also interacts with the catalytic core to augment Gαs-stimulatory and Gαi-inhibitory activity.
N-Terminus and G-Protein Interactions.
In our previous studies, we proposed a model for Gβγ activation of AC5/6 that involved the release of Gβγ upon receptor-stimulated activation of Gs, where both subunits were required for full activation by agonist. We suggested that it is the Gβγ released upon activation of Gs that stimulates AC, serving to enhance regulation by the alpha-s subunit (Gao et al., 2007) . Herein we show that, GDP bound Gαs also directly binds to 5NT and that GDP-Gαs and Gβγ do not compete for binding on 5NT rather enhance binding to
5NT. Gel filtration studies confirmed the binding of G-protein subunits as a heterotrimer to 5NT
and endogenous Gαs and Gβγ co-purified with AC5 from immunoprecipitates of HEK293 cells.
Existence of G-proteins and AC as a stable complex was first proposed by Levitzki in 1988 , (Bar-Sinai et al., 1992 Levitzki, 1988; Levitzki and Klein, 2002) based upon copurification of AC and G-proteins from turkey erythrocyte membranes that was independent of the activation state of the G-proteins. There is now additional evidence that other effectors namely GIRK channel (Kir 3.1) (Peleg et al., 2002) , phospholipase Cβ (PLCβ) (Yuan et al., 2007) , and RACK1 (Dell et al., 2002) exist as stable complexes with G-protein heterotrimers. In the case of PLCβ, the activator of G protein signaling AGS8 forms a complex with both Gαi·βγ and PLCβ. Gβγ activates PLCβ through the non-dissociated heterotrimer complex using an alternate interaction site, not the "hot spot" on Gβγ normally associated with effector interactions (Smrcka, 2008; Yuan et al., 2007) . For the GIRK channel, it is the N-terminus of GIRK1 that This article has not been copyedited and formatted. The final version may differ from this version. In an inactive Gα·βγ complex, the effector surface of Gα, and Gβγ are masked. It is only upon activation of the alpha subunit and subunit dissociation that effector interaction sites are exposed. In our case, it is unlikely that the normal effector face of Gαs is responsible for interactions with 5NT, as it is likely masked by Gβγ binding. This is supported by the fact that addition of excess 5NT does not sequester Gαs to reduce Gαs-stimulated AC5 activity (Fig S7) . domains were not stimulated by Gβγ in absence or presence of 5NT (Fig. S8) , suggesting that the three cytoplasmic domains of AC5 are not sufficient for conditional stimulation by Gβγ. This is consistent with the fact that the cytoplasmic domains alone are not sufficient for conditional stimulation of AC2 by Gβγ Weitmann et al., 2001) . Thus, it is likely that the AC5 membrane domains must properly orient the cytoplasmic domains for Gβγ activation.
Mechanism of Gβγ
We have previously mapped the Gβγ binding and activation site on AC6 to the NT This article has not been copyedited and formatted. The final version may differ from this version. residues 77-151 (Gao et al., 2007) and now show that both GDP-Gαs and Gβγ directly bind to 6NT (Fig. S3) . As opposed to AC5, deletion of the Gβγ binding site on AC6-NT abolished stimulation by exogenously added Gβγ. The NT of all 9 isoforms of AC are highly variable even among the closely related isoforms, AC5 and AC6. So the possibility of somewhat different mechanisms of activation by Gβγ is not completely unexpected. In fact AC5 and AC6 also display differences in their stimulation by Gαs, inhibition by Gαi, and phosphorylation by protein kinase C (Chen-Goodspeed et al., 2005; Harry et al., 1997; Lai et al., 1999) .
Role of N-Terminus in Modulating
Activity. The divergence of the N-terminus provides additional regulatory specificity among the 9 isoforms of AC. Numerous physiological regulators bind to the NT of ACs, but in most cases the mechanism for regulation of AC activity is unclear. Previous binding assays using in vitro translated proteins suggested that AC6 NT contacts the C1 domain to modulate Gαi-mediated inhibition . We have now
shown that there is a direct interaction between AC5 NT and C1/C2 domains which increases catalytic activity, and similar to AC6, limits the inhibition by Gαi. Gβγ relieves the constraints of the N-terminus on Gαi, although it is unclear if this is due to direct binding to 5NT or to an allosteric effect of the Gβγ activation site. However, Gβγ binding to 5NT does not compete with 5NT-C1 binding, thus it is unlikely to be a simple competition between interaction sites.
Post-translational modifications or direct binding to AC NT by other factors may also
regulate activity by altering the interaction between NT and C1/C2 domains. For example, phosphorylation of AC6 NT by PKC δ and ε inhibits AC6 activity (Lai et al., 1999; Lai et al., 1997; Lin et al., 2002) ; whereas AC8 NT forms part of the calmodulin binding site that stimulates AC8 activity, although the precise mechanism for either regulation is still unclear (Simpson et al., 2006) . Alternatively, the NT of ACs may simply serve as a scaffold to facilitate This article has not been copyedited and formatted. The final version may differ from this version. interactions between regulators and the catalytic domains. For example, AC5 NT also interacts with the G protein exchange factor RiC8a to suppress AC activity (Wang et al., 2007) . The NT of AC2 binds to the AKAP scaffolding protein, Yotiao, facilitating inhibition by a yet unknown regulator (Piggott et al., 2008) . Finally, both AC5 and AC6 NT bind Gβγ to conditionally stimulate the enzyme, although they differ in their mechanism as discussed above (Gao et al., 2007) . The possibility for NT regulation of ACs allows for even more diverse modulation of these complex enzymes.
Possible Physiological Consequences
The question arises as to what is the functional role of heterotrimer binding to the N-terminus of AC5. FRET measurements and immunoprecipitations confirm the stable interaction of Gβγ to AC5 in cells. Prior reports from BRET studies indicate that Gβγ traffics together with AC2 (and also with GIRK) to the plasma membrane (Rebois et al., 2006) . The deletion of the NT Gβγ binding site had no effect on trafficking of AC5 to the PM, and we observe no FRET between AC5 and Gβγ on intracellular sites within the cell. Thus it does not appear that heterotrimer binding to the N-terminus is required for proper trafficking of AC5. Another possible effect could be on AC5 activity, as is the case of GIRK channel. Heterotrimer binding to a scaffold formed by NT and CT of GIRK1 lowers the basal activity of GIRK1 and predisposes the channel to GPCR mediated activation (Rubinstein et al., 2009) . Our model of heterotrimeric G-protein scaffolding by AC5 resembles the activation of GIRK channels by Gβγ, since both effectors bind G protein heterotrimers on their NT yet the Gβγ activation site is distinct from the NT at a secondary location on each effector. We hypothesize that the NT of AC5 brings catalytic core and regulators (heterotrimeric G-protein subunits) in close proximity to prepare for potential GPCR mediated activation of AC.
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